1-156868640-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002529.4(NTRK1):​c.710C>T​(p.Thr237Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00315 in 1,550,790 control chromosomes in the GnomAD database, including 132 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T237A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.016 ( 72 hom., cov: 33)
Exomes 𝑓: 0.0017 ( 60 hom. )

Consequence

NTRK1
NM_002529.4 missense

Scores

4
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.347

Publications

9 publications found
Variant links:
Genes affected
NTRK1 (HGNC:8031): (neurotrophic receptor tyrosine kinase 1) This gene encodes a member of the neurotrophic tyrosine kinase receptor (NTKR) family. This kinase is a membrane-bound receptor that, upon neurotrophin binding, phosphorylates itself and members of the MAPK pathway. The presence of this kinase leads to cell differentiation and may play a role in specifying sensory neuron subtypes. Mutations in this gene have been associated with congenital insensitivity to pain, anhidrosis, self-mutilating behavior, cognitive disability and cancer. Alternate transcriptional splice variants of this gene have been found, but only three have been characterized to date. [provided by RefSeq, Jul 2008]
NTRK1 Gene-Disease associations (from GenCC):
  • hereditary sensory and autonomic neuropathy type 4
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
  • familial medullary thyroid carcinoma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002357781).
BP6
Variant 1-156868640-C-T is Benign according to our data. Variant chr1-156868640-C-T is described in ClinVar as Benign. ClinVar VariationId is 198111.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.055 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NTRK1NM_002529.4 linkc.710C>T p.Thr237Met missense_variant Exon 6 of 17 ENST00000524377.7 NP_002520.2
NTRK1NM_001012331.2 linkc.710C>T p.Thr237Met missense_variant Exon 6 of 16 NP_001012331.1
NTRK1NM_001007792.1 linkc.620C>T p.Thr207Met missense_variant Exon 7 of 17 NP_001007793.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NTRK1ENST00000524377.7 linkc.710C>T p.Thr237Met missense_variant Exon 6 of 17 1 NM_002529.4 ENSP00000431418.1

Frequencies

GnomAD3 genomes
AF:
0.0164
AC:
2497
AN:
152164
Hom.:
72
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0570
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00694
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000620
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00909
GnomAD2 exomes
AF:
0.00401
AC:
619
AN:
154444
AF XY:
0.00317
show subpopulations
Gnomad AFR exome
AF:
0.0578
Gnomad AMR exome
AF:
0.00388
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000671
Gnomad OTH exome
AF:
0.00364
GnomAD4 exome
AF:
0.00170
AC:
2381
AN:
1398508
Hom.:
60
Cov.:
33
AF XY:
0.00149
AC XY:
1031
AN XY:
689830
show subpopulations
African (AFR)
AF:
0.0580
AC:
1832
AN:
31594
American (AMR)
AF:
0.00434
AC:
155
AN:
35708
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25180
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35738
South Asian (SAS)
AF:
0.000379
AC:
30
AN:
79232
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48480
Middle Eastern (MID)
AF:
0.00339
AC:
19
AN:
5606
European-Non Finnish (NFE)
AF:
0.000102
AC:
110
AN:
1078982
Other (OTH)
AF:
0.00405
AC:
235
AN:
57988
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
158
316
474
632
790
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
58
116
174
232
290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0164
AC:
2500
AN:
152282
Hom.:
72
Cov.:
33
AF XY:
0.0157
AC XY:
1168
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.0569
AC:
2363
AN:
41540
American (AMR)
AF:
0.00693
AC:
106
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
68014
Other (OTH)
AF:
0.00900
AC:
19
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
121
243
364
486
607
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00770
Hom.:
71
Bravo
AF:
0.0185
ESP6500AA
AF:
0.0479
AC:
196
ESP6500EA
AF:
0.000623
AC:
5
ExAC
AF:
0.00316
AC:
225
Asia WGS
AF:
0.00289
AC:
10
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hereditary insensitivity to pain with anhidrosis Benign:7
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Oct 15, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 06, 2017
Counsyl
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -

not specified Benign:2
Jun 05, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

May 26, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Sep 28, 2015
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
18
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.55
.;.;D;T
Eigen
Benign
-0.11
Eigen_PC
Benign
-0.23
FATHMM_MKL
Benign
0.18
N
LIST_S2
Uncertain
0.87
D;D;D;D
MetaRNN
Benign
0.0024
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.5
.;M;M;.
PhyloP100
0.35
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-1.1
N;N;N;N
REVEL
Benign
0.046
Sift
Benign
0.14
T;T;T;T
Sift4G
Benign
0.19
T;T;T;T
Polyphen
1.0
.;D;D;.
Vest4
0.25
MVP
0.90
MPC
0.29
ClinPred
0.0054
T
GERP RS
2.5
Varity_R
0.035
gMVP
0.62
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs55909005; hg19: chr1-156838432; COSMIC: COSV62325267; COSMIC: COSV62325267; API